These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36883603)

  • 1. Fears and hopes of patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic across Europe. Results from the REUMAVID study (phase 1 and phase 2).
    Garrido-Cumbrera M; Christen L; Marzo-Ortega H; Correa-Fernández J; Sanz-Gomez S; Navarro-Compán V
    Musculoskeletal Care; 2023 Sep; 21(3):932-935. PubMed ID: 36883603
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Correa-Fernández J; Sanz-Gómez S; Navarro-Compán V;
    Clin Exp Rheumatol; 2022 May; 40(5):1062-1063. PubMed ID: 35084328
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Plazuelo-Ramos P; Webb D; Jacklin C; Irwin S; Grange L; Makri S; Frazão Mateus E; Mingolla S; Antonopoulou K; Sanz-Gómez S; Correa-Fernández J; Carmona L; Navarro-Compán V
    RMD Open; 2021 Apr; 7(1):. PubMed ID: 33827969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
    Al Nokhatha S; MacEoin N; Conway R
    Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
    Dejaco C; Bijlsma JW; Buttgereit F
    Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
    [No Abstract]   [Full Text] [Related]  

  • 6. Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
    Nikiphorou E; Alpizar-Rodriguez D; Gastelum-Strozzi A; Buch M; Peláez-Ballestas I
    Rheumatology (Oxford); 2021 May; 60(5):2040-2045. PubMed ID: 33496334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unauthorized change of immunosuppressants by patients with rheumatic diseases in the COVID-19 pandemic: a cross-sectional analysis of a patient survey.
    Dahm S; Henes JC; Saur SJ
    Rheumatol Int; 2023 Jul; 43(7):1363-1367. PubMed ID: 36988675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.
    Dejaco C; Alunno A; Bijlsma JW; Boonen A; Combe B; Finckh A; Machado PM; Padjen I; Sivera F; Stamm TA; Buttgereit F
    Ann Rheum Dis; 2021 Apr; 80(4):518-526. PubMed ID: 33158877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of podiatry telephone appointments for people with rheumatic and musculoskeletal diseases.
    Palmer JL; Siddle HJ; Redmond AC; Alcacer-Pitarch B
    J Foot Ankle Res; 2021 Jan; 14(1):4. PubMed ID: 33413562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of COVID‑19 Patients with Rheumatic and Musculoskeletal Diseases: A Single Centre Cohort Study.
    Mazeda C; Barcelos A
    Acta Med Port; 2023 Feb; 36(2):140-141. PubMed ID: 36738184
    [No Abstract]   [Full Text] [Related]  

  • 11. Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case-control study.
    Gastelum-Strozzi A; Pascual V; Hernández-Garduño A; Moctezuma-Rios JF; Guaracha-Basañez GA; Sotelo T; Garcia-Garcia C; Contreras-Yañez I; Álvarez-Hernández E; Infante-Castañeda C; Peláez-Ballestas I
    Clin Rheumatol; 2022 Oct; 41(10):3211-3218. PubMed ID: 35790594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19, rheumatic diseases and immune dysregulation-a perspective.
    Tariq S; Van Eeden C; Tervaert JWC; Osman MS
    Clin Rheumatol; 2021 Feb; 40(2):433-442. PubMed ID: 33411143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
    Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
    Kitas GD; Dimitroulas T
    Int J Rheum Dis; 2021 Apr; 24(4):473-476. PubMed ID: 33817989
    [No Abstract]   [Full Text] [Related]  

  • 15. Research priority setting by young people with rheumatic musculoskeletal disease.
    McDonagh JE; Lunt L; Cresswell K; Parsons S; Tattersall R;
    Arch Dis Child; 2019 Feb; 104(2):204. PubMed ID: 30007947
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
    Adnine A; Soussan I; Nadiri K; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
    Curr Rheumatol Rev; 2021 Aug; 17(3):318-326. PubMed ID: 33371850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fears about COVID-19 and perceived risk among people with rheumatoid arthritis or ankylosing spondylitis following the initial lockdown in Aotearoa New Zealand.
    Treharne GJ; Johnstone G; Fletcher BD; Lamar RSM; White D; Stebbings S; Harrison A
    Musculoskeletal Care; 2022 Jun; 20(2):290-298. PubMed ID: 34388290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the COVID-19 pandemic on people with rheumatic and musculoskeletal diseases: insights from patient-generated data on social media.
    Reuter K; Deodhar A; Makri S; Zimmer M; Berenbaum F; Nikiphorou E
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI77-SI84. PubMed ID: 33629107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 Pandemic on the Employment of Canadian Young Adults With Rheumatic Disease: Findings From a Longitudinal Survey.
    Jetha A; Tucker LB; Chen C; Gignac MAM
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1146-1152. PubMed ID: 33973377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak.
    Sonaglia A; Comoretto R; Pasut E; Treppo E; Del Frate G; Colatutto D; Zabotti A; De Vita S; Quartuccio L
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.